PortfoliosLab logoPortfoliosLab logo
Alector, Inc. (ALEC)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US0144421072
CUSIP
014442107
IPO Date
Feb 7, 2019

Highlights

EPS (TTM)
-$1.06
Total Revenue (TTM)
$69.05M
Gross Profit (TTM)
$22.59M
EBITDA (TTM)
-$112.36M
Year Range
$0.87 - $3.40
Target Price
$3.25
ROA (TTM)
-36.74%
ROE (TTM)
-351.52%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Alector, Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Alector, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Alector, Inc. (ALEC) has returned 37.82% so far this year and 74.80% over the past 12 months.


Alector, Inc.

1D
6.44%
1M
-11.52%
YTD
37.82%
6M
-27.36%
1Y
74.80%
3Y*
-29.71%
5Y*
-35.99%
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Feb 7, 2019, ALEC's average daily return is +0.02%, while the average monthly return is -0.39%.

Historically, 44% of months were positive and 56% were negative. The best month was Jan 2020 with a return of +62.2%, while the worst month was Oct 2025 at -50.3%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 9 months.

On a daily basis, ALEC closed higher 50% of trading days. The best single day was Jul 2, 2021 with a return of +57.1%, while the worst single day was Oct 22, 2025 at -49.8%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202621.15%28.57%-11.52%37.82%
2025-12.17%-1.20%-25.00%-2.44%10.83%5.26%6.43%57.72%25.96%-50.34%-9.52%17.29%-17.46%
2024-25.31%16.95%-13.63%-15.61%-3.15%-7.72%32.16%-12.00%-11.74%5.58%-47.36%-27.03%-76.32%
2023-4.44%-3.17%-27.52%6.62%12.73%-19.22%14.14%-20.55%18.90%-19.75%4.23%47.23%-13.54%
2022-23.20%-0.13%-10.04%-32.63%-7.71%14.67%0.59%1.27%-8.60%-2.75%-7.72%8.72%-55.30%
202111.30%7.96%10.78%-3.18%-8.72%17.02%15.39%12.46%-15.58%-4.73%-5.01%-0.00%36.48%

Benchmark Metrics

Alector, Inc. has an annualized alpha of -14.29%, beta of 1.48, and R² of 0.12 versus S&P 500 Index. Calculated based on daily prices since February 08, 2019.

  • This stock participated in 130.23% of S&P 500 Index downside but only -11.72% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.12 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-14.29%
Beta
1.48
0.12
Upside Capture
-11.72%
Downside Capture
130.23%

Return for Risk

Risk / Return Rank

ALEC ranks 66 for risk / return — better than 66% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


ALEC Risk / Return Rank: 6666
Overall Rank
ALEC Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
ALEC Sortino Ratio Rank: 6969
Sortino Ratio Rank
ALEC Omega Ratio Rank: 7272
Omega Ratio Rank
ALEC Calmar Ratio Rank: 6363
Calmar Ratio Rank
ALEC Martin Ratio Rank: 6060
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Alector, Inc. (ALEC) and compare them to a chosen benchmark (S&P 500 Index).


ALECBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.71

0.90

-0.19

Sortino ratio

Return per unit of downside risk

1.60

1.39

+0.22

Omega ratio

Gain probability vs. loss probability

1.23

1.21

+0.02

Calmar ratio

Return relative to maximum drawdown

1.02

1.40

-0.38

Martin ratio

Return relative to average drawdown

1.99

6.61

-4.62

Explore ALEC risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Alector, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Alector, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Alector, Inc. was 97.71%, occurring on Apr 10, 2025. The portfolio has not yet recovered.

The current Alector, Inc. drawdown is 94.56%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-97.71%Jul 8, 2021945Apr 10, 2025
-73.36%Feb 10, 2020177Oct 20, 2020177Jul 6, 2021354
-46.37%Apr 15, 2019124Oct 9, 201977Jan 30, 2020201
-29.02%Feb 25, 201911Mar 11, 201918Apr 4, 201929
-9.44%Feb 8, 20191Feb 8, 20193Feb 13, 20194

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Alector, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Alector, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for ALEC relative to other companies in the Biotechnology industry. Currently, ALEC has a P/S ratio of 3.2. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items